ConductScience.org, home

Paper20042704

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.

Petersen RC and 11 others. Neurology, 2010. Cited by 1,889 papers, by iCite.

Cite this record

ConductScience Library. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Papers, record 20042704. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20042704

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.
PubMed
Journal
Neurology
PubMed
Year
2010
PubMed
Publication types
Comparative Study, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
1,889
iCite
Relative citation ratio, by iCite
53.2
iCite
Revised in PubMed
2025-05-29
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Petersen RCR C
2Aisen PSP S
3Beckett LAL A
4Donohue MCM C
5Gamst ACA C
6Harvey DJD J
7Jack CR JrC R
8Jagust WJW J
9Shaw LML M
10Toga AWA W
11Trojanowski JQJ Q
12Weiner MWM W

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Diagnostic ImagingMajor topic
Aged
Aged, 80 and over
Biomarkers
Cross-Sectional Studies
Female
Follow-Up Studies
Humans
Longitudinal Studies
Male
Middle Aged

Source PubMed

Download CSV of topics

Grants85

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 AG023501NIA NIH HHSUnited StatesP50AG023501PubMed and NIHNIH RePORTER
UO1 AG029213-01NIA NIH HHSUnited StatesUO1AG029213PubMedNIH RePORTER
2 P50 AG016570NIA NIH HHSUnited StatesP50AG016570PubMed and NIHNIH RePORTER
1 U01 AG24904NIA NIH HHSUnited StatesU01AG024904PubMed and NIHNIH RePORTER
R01AG029672NIA NIH HHSUnited StatesR01AG029672PubMed and NIHNIH RePORTER
1P01 AG-19724-07NIA NIH HHSUnited StatesP01AG197240PubMedNIH RePORTER
AG031224NIA NIH HHSUnited StatesR01AG031224PubMed and NIHNIH RePORTER
P50 NS053488-02NINDS NIH HHSUnited StatesP50NS053488PubMed and NIHNIH RePORTER
AG027984NIA NIH HHSUnited StatesR01AG027984PubMed and NIHNIH RePORTER
P50 AG16574NIA NIH HHSUnited StatesP50AG016574PubMed and NIHNIH RePORTER
5 P41 RR013642NCRR NIH HHSUnited StatesP41RR013642PubMed and NIHNIH RePORTER
1U01AG24904NIA NIH HHSUnited StatesU01AG024904PubMed and NIHNIH RePORTER
9 P01 EB 001955-11NIBIB NIH HHSUnited StatesP01EB001955PubMed and NIHNIH RePORTER
1 R01 EB 006266-01NIBIB NIH HHSUnited StatesR01EB006266PubMed and NIHNIH RePORTER
2 R01LM005639NLM NIH HHSUnited StatesR01LM005639PubMed and NIHNIH RePORTER
1KL2RR024144-01NCRR NIH HHSUnited StatesKL2RR024144PubMed and NIHNIH RePORTER
P01 AG 09215-20NIA NIH HHSUnited StatesP01AG092152PubMedNIH RePORTER
R01 AG10897NIA NIH HHSUnited StatesR01AG010897PubMed and NIHNIH RePORTER
1RC2AG036535-01NIA NIH HHSUnited StatesRC2AG036535PubMed and NIHNIH RePORTER
RL1NS062412NINDS NIH HHSUnited StatesRL1NS062412PubMed and NIHNIH RePORTER

See all 85 grantsDownload CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01078636Alzheimer's Disease Neuroimaging Initiative Grand OpportunityBackgroundClinicalTrials.gov
NCT01231971Alzheimer's Disease Neuroimaging Initiative 2BackgroundClinicalTrials.gov

Download CSV of trials

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116631882Mild cognitive impairment.Lancet2006https://conductscience.org/library/papers/16631882PubMed
215324362Mild cognitive impairment as a diagnostic entity.J Intern Med2004https://conductscience.org/library/papers/15324362PubMed
310190820Mild cognitive impairment: clinical characterization and outcome.Arch Neurol1999https://conductscience.org/library/papers/10190820PubMed
41164215Cerebral blood flow in dementia.Arch Neurol1975https://conductscience.org/library/papers/1164215PubMed
57168798Random-effects models for longitudinal data.Biometrics1982https://conductscience.org/library/papers/7168798PubMed
616682537Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.Arch Neurol2006https://conductscience.org/library/papers/16682537PubMed
76610841Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.Neurology1984https://conductscience.org/library/papers/6610841PubMed
810227624Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.Neurology1999https://conductscience.org/library/papers/10227624PubMed
916682536Neuropathologic features of amnestic mild cognitive impairment.Arch Neurol2006https://conductscience.org/library/papers/16682536PubMed
109106355Amyloid, the presenilins and Alzheimer's disease.Trends Neurosci1997https://conductscience.org/library/papers/9106355PubMed
1115742005A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment.Neuropsychopharmacology2005https://conductscience.org/library/papers/15742005PubMed
1215829527Vitamin E and donepezil for the treatment of mild cognitive impairment.N Engl J Med2005https://conductscience.org/library/papers/15829527PubMed
1316488378Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.Lancet Neurol2006https://conductscience.org/library/papers/16488378PubMed
1417347655Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.Nat Rev Drug Discov2007https://conductscience.org/library/papers/17347655PubMed
1517509485Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.Lancet Neurol2007https://conductscience.org/library/papers/17509485PubMed
166496779A new rating scale for Alzheimer's disease.Am J Psychiatry1984https://conductscience.org/library/papers/6496779PubMed
177991117The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.Neurology1994https://conductscience.org/library/papers/7991117PubMed
1818322263Safety and efficacy of galantamine in subjects with mild cognitive impairment.Neurology2008https://conductscience.org/library/papers/18322263PubMed
197183759Development and validation of a geriatric depression screening scale: a preliminary report.J Psychiatr Res1982https://conductscience.org/library/papers/7183759PubMed

Download CSV of references

Cited by1,440

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,889 citations.

PMIDTitleJournalYearIn PapersSource
42988805Exploring the relationship between methylation of the cortisol receptor genes and brain and cognitive outcomes in individuals with elevated amyloid-β.Transl Psychiatry2026https://conductscience.org/library/papers/42988805PubMed
42967904A model of brain function to predict tau across Alzheimer's disease and related disorders.Nat Commun2026https://conductscience.org/library/papers/42967904PubMed
42948157Heterogeneous progression of AT(N) biomarkers in data-driven subtypes of Alzheimer's disease.Front Aging Neurosci2026https://conductscience.org/library/papers/42948157PubMed
42938161Predicting MCI-to-Alzheimer's Conversion: A Systematic Benchmark of Classical, Machine Learning, and Deep Survival Models.Diagnostics (Basel)2026https://conductscience.org/library/papers/42938161PubMed
42936906Pathway-specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease.Alzheimers Dement2026https://conductscience.org/library/papers/42936906PubMed
42928439Blood transcriptomic signatures of vascular risk in Alzheimer's disease.Alzheimers Dement2026https://conductscience.org/library/papers/42928439PubMed
42926671A Pipeline for ADNI Resting-State Functional MRI Processing and Quality Control.Res Sq2026https://conductscience.org/library/papers/42926671PubMed
42926376Imputation-Based Harmonization Mitigates Site Effects Without Data Leakage in Machine Learning Studies.bioRxiv2026https://conductscience.org/library/papers/42926376PubMed
42922840Comparative Value of Cognitive and Functional Assessments for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer's Disease: An ADNI Cohort Study.medRxiv2026https://conductscience.org/library/papers/42922840PubMed
42922830Systematic Modality Ablation of Multimodal Machine Learning for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer's Disease.medRxiv2026https://conductscience.org/library/papers/42922830PubMed
42911836Stochastic Siamese MAE Pretraining for Longitudinal Medical Images.IEEE Trans Med Imaging2026https://conductscience.org/library/papers/42911836PubMed
42909513APOE ε4 accelerates plasma p-tau217 trajectory: a Bayesian joint longitudinal analysis of ADNI.Neurol Sci2026https://conductscience.org/library/papers/42909513PubMed
42897700A Two-Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p-Tau217 Gray Zone.Ann Clin Transl Neurol2026https://conductscience.org/library/papers/42897700PubMed
42889485No evidence that serum metabolite slopes improve held-out prediction of clinical progression in the Alzheimer's disease neuroimaging initiative.Front Aging Neurosci2026https://conductscience.org/library/papers/42889485PubMed
42877469A multivariate plasma pathology-cognition axis reveals biologically anchored residual cognitive heterogeneity across the Alzheimer's disease clinical spectrum.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/42877469PubMed
42860384Data‑driven cognitive composites predict Aβ‑related decline and progression to MCI: the ADOPIC study.Alzheimers Dement2026https://conductscience.org/library/papers/42860384PubMed
42857586Discovering Heterogeneous Neurodegenerative Disease Patterns From MRI Data for Improved Prediction.Med Image Comput Comput Assist Interv2027https://conductscience.org/library/papers/42857586PubMed
42856420Diagnostic Utility of Multi-Domain Language Measures Across the Alzheimer Disease Continuum.medRxiv2026https://conductscience.org/library/papers/42856420PubMed
42856413Anatomically Guided Deep Learning Reconstruction of Accelerated Snapshot CEST MRI.bioRxiv2026https://conductscience.org/library/papers/42856413PubMed
42851145Proteomic dysregulation associated with cerebral amyloid angiopathy.Alzheimers Dement2026https://conductscience.org/library/papers/42851145PubMed

See all 1,440 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APP351PubTator's text mininghttps://conductscience.org/library/genes/351

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20042704

GET https://conductscience.org/api/papers/v1/20042704/grants?page=2